HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR Will Seek Trichloroethane Data, FDA Input For Ingredient Review

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel is seeking data on the safety of trichloroethane in cosmetics, the panel announced during a meeting Sept. 9-10 in Washington, D.C. CIR decided to proceed with a safety review although the Environmental Protection Agency currently prohibits production of the ingredient

You may also be interested in...



CIR Panel Focuses On Hair-Dye Ingredients, Troublesome Phenylenediamines

Hair-dye ingredients dominated the June 4-5 meeting of the Cosmetic Ingredient Review Expert Panel in Washington, D.C., with the panel taking in a presentation meant to aid its review of the problematic phenylenediamine family before moving on to determine the fate of seven cosmetic ingredients in total

CIR Panel Focuses On Hair-Dye Ingredients, Troublesome Phenylenediamines

Hair-dye ingredients dominated the June 4-5 meeting of the Cosmetic Ingredient Review Expert Panel in Washington, D.C., with the panel taking in a presentation meant to aid its review of the problematic phenylenediamine family before moving on to determine the fate of seven cosmetic ingredients in total

CIR To Consider New Data On Retinol During 2005 Review

The Cosmetic Ingredient Review Expert Panel plans to re-review retinol and retinyl palmitate during a meeting in June, the panel announced. CIR last reviewed the ingredients in 1987, concluding they are safe for use in cosmetics in concentrations up to 5%

Related Content

UsernamePublicRestriction

Register

RS012454

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel